| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/25/1996 | WO1996012184A1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings |
| 04/25/1996 | WO1996012022A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 04/25/1996 | WO1996012020A2 Hemoglobin receptors from neisseriae |
| 04/25/1996 | WO1996011953A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | WO1996011944A1 Synthetic peptides and vaccines comprising same |
| 04/25/1996 | WO1996011932A1 2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials |
| 04/25/1996 | WO1996011924A1 Substituted spiroalkylamino and spiroalkoxy-heterocycles, process for preparing the same and their use as pesticides and fungicides |
| 04/25/1996 | WO1995030670A3 Pyranone compounds useful to treat retroviral infections |
| 04/25/1996 | CA2472085A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | CA2203116A1 Hemoglobin receptors from neisseriae |
| 04/25/1996 | CA2202465A1 Process for the diagnostic assessment and monitoring, as well as medicaments for the therapy of states of shock in humans |
| 04/25/1996 | CA2202459A1 Substituted spiroalkylamino and -alkoxy heterocycles, process for their preparation, and their use as pesticides and fungicides |
| 04/24/1996 | EP0708093A1 Quinoxalines, process for their preparation, and their use |
| 04/24/1996 | EP0708085A2 Antiviral ethers of aspartate protease substrate isosteres |
| 04/24/1996 | EP0707855A2 Combination therapy for chronic hepatitis C infection |
| 04/24/1996 | EP0707854A2 Compositions for the treatment of gastronitestinal disorders containing bismuth and an antimicrobial |
| 04/24/1996 | EP0707851A2 Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents |
| 04/24/1996 | EP0707652A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
| 04/24/1996 | EP0707638A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/24/1996 | EP0707591A1 Methylphosphonic acid ester, process for preparing the same and its use |
| 04/24/1996 | EP0707496A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE |
| 04/24/1996 | EP0707488A1 Cyclohexapeptidyl amine compounds |
| 04/24/1996 | EP0707482A1 Erythromycin derivatives |
| 04/24/1996 | EP0707481A1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 04/24/1996 | EP0689545A4 Macrocyclic amide and urea immunomodulators |
| 04/24/1996 | EP0625194B1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 04/24/1996 | EP0533825B1 Ether lipid-nucleoside covalent conjugates |
| 04/24/1996 | CN1121357A Hepatitis B escape mutant specific binding molecules |
| 04/24/1996 | CN1121312A Chlamydia vaccine and process |
| 04/24/1996 | CN1121311A Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 04/24/1996 | CN1121075A Alkaloids from mappia foetida, the use thereof and formulations containing them |
| 04/23/1996 | US5510388 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/23/1996 | US5510343 Bicyclic and tricyclic β-lactams |
| 04/23/1996 | US5510330 Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
| 04/23/1996 | US5510258 Porcine reproductive and respiratory syndrome virus antigen and processes for the preparation and use of said antigen in vaccines and diagnostics |
| 04/23/1996 | US5510104 Administering a selective alpha-amino acids or their alkyl esters in presence of halide; microbiocides; myeloperoxidase, eosinophil peroxidase |
| 04/20/1996 | CA2160859A1 Quinoxalines, a process for their preparation, and their use |
| 04/20/1996 | CA2160763A1 Antiviral ethers of aspartate protease substrate isosteres |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011273A1 Papillomavirus vaccine |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011258A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 04/18/1996 | WO1996011257A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 04/18/1996 | WO1996011210A1 Cyclic hexapeptides having antibiotic activity |
| 04/18/1996 | WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | WO1996011208A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/18/1996 | WO1996011205A1 Peptide nucleic acid conjugates |
| 04/18/1996 | WO1996011200A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | WO1996011004A1 Agent for treating papilloma virus-positive malignant and premalignant lesions |
| 04/18/1996 | WO1996010997A1 Hepatitis virus vaccines |
| 04/18/1996 | WO1996010989A1 Use and composition of an anti-sexually transmitted diseases formulation |
| 04/18/1996 | WO1996010912A1 Method for reducing unwanted cellular adhesions |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | WO1996005288A3 T cell activation |
| 04/18/1996 | DE4436509A1 Substituierte Spiroalkylamino- und alkoxy-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide And alkoxy-substituted Spiroalkylamino- heterocycles, to processes for their preparation and their use as pesticides and fungicides |
| 04/18/1996 | DE4436352A1 Verfahren zur diagnostischen Beurteilung und Verlaufskontrolle sowie Arzneimittel zur Therapie von Schockzuständen beim Menschen Method for the diagnostic assessment and monitoring and drugs for the treatment of shock in humans |
| 04/18/1996 | CA2202088A1 Hepatitis virus vaccines |
| 04/18/1996 | CA2202029A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 04/18/1996 | CA2202027A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 04/18/1996 | CA2201872A1 Use and composition of an anti-sexually transmitted diseases formulation |
| 04/18/1996 | CA2201773A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/17/1996 | EP0706795A2 Catechol diether compounds as inhibitors of TNF release |
| 04/17/1996 | EP0706530A1 Liponucleotides of desoxynucleosides, their preaparation and their use as anti-viral drugs |
| 04/17/1996 | EP0706528A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 04/17/1996 | EP0706523A1 Substituted arylthioalkylthiopyridines |
| 04/17/1996 | EP0706521A1 Novel imides |
| 04/17/1996 | EP0706514A1 Compounds and methods for inhibition of hiv and related viruses |
| 04/17/1996 | EP0706400A1 Therapeutic formulation and method |
| 04/17/1996 | EP0706394A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 04/17/1996 | EP0706393A1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone |
| 04/17/1996 | EP0706387A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/17/1996 | EP0706384A1 Diamondoid derivatives for pharmaceutical use |
| 04/17/1996 | EP0558673B1 Retroviral protease inhibitors |
| 04/17/1996 | EP0428596B1 Novel infectious bursal disease virus |
| 04/17/1996 | EP0424519B1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
| 04/17/1996 | EP0290565B1 Vaccine containing tick antigens |
| 04/16/1996 | US5508310 Immunopotentiatory agents and physiologically acceptable salts thereof |
| 04/16/1996 | US5508294 Sulfonylalkanoylamino hydroxyethlamino sulfonamides useful as retroviral protease inhibitors |
| 04/16/1996 | US5508290 Hindered N-oxide esters of rapamycin |
| 04/16/1996 | US5508286 Rapamycin amidino carbamates |
| 04/16/1996 | US5508285 Hindered N-oxide esters of rapamycin |
| 04/16/1996 | US5508278 Bactericides |
| 04/16/1996 | US5508269 Aminoglycoside formulation for aerosolization |
| 04/16/1996 | US5508186 Has vp1 minor structural protein to vp2 major structural protein ratio higher than the ratio of naturally occurring full capsid |
| 04/16/1996 | US5507932 Apparatus for electrolyzing fluids |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010580A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | WO1996010549A1 Compounds for the suppression of hiv tat transactivation |
| 04/11/1996 | WO1996010421A1 Vaccine compositions |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010416A1 DRUGS CONTAINING β-INTERFERON |
| 04/11/1996 | WO1996010399A1 Liposome-formulations for treatment of viral diseases |
| 04/11/1996 | DE4435661A1 Mittel zur Behandlung von Papillomvirus-positiven gutartigen, malignen und prämalignen Läsionen Agents for the treatment of papilloma virus-positive benign, malignant and pre-malignant lesions |
| 04/11/1996 | CA2199154A1 The use of medicaments containing interferon-beta |
| 04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
| 04/10/1996 | EP0705828A1 Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents |
| 04/10/1996 | EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production |
| 04/10/1996 | EP0705335A1 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |